Stockreport

OnKure Therapeutics to Participate in Upcoming Investor Conferences

OnKure Therapeutics, Inc. - Class A  (OKUR) 
PDF BOULDER, Colo., Nov. 04, 2025 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of no [Read more]